A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Oral Administration of a Heat-Treated Lactobacillus paracasei Supplement in Infants with Atopic Dermatitis Receiving Topical Corticosteroid Therapy

被引:26
|
作者
Yan, Dah-Chin [1 ]
Hung, Chih-Hsing [2 ]
Sy, Leticia B. [3 ]
Lue, Ko-Huang [4 ]
Shih, I-Hsin [5 ]
Yang, Chin-Yi [5 ]
Chen, Li-Chen [5 ]
Sun, Hai-Lun [4 ]
Lee, Min-Sheng [6 ]
Chambard, Julie [7 ]
Tanguy, Jerome [7 ]
Hughes-Formella, Betsy
Nutten, Sophie [7 ]
Blanchard, Carine [7 ]
机构
[1] Taipei Chang Gung Mem Hosp, Taipei, Taiwan
[2] Kaohsiung Municipal Hsiaokang Hosp, Kaohsiung, Taiwan
[3] Cardinal Tien Hosp, New Taipei, Taiwan
[4] Chung Shan Med Univ Hosp, Taichung, Taiwan
[5] Linkou Chang Gung Mem Hosp, Taoyuan, Taiwan
[6] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan
[7] Nestle Res, Lausanne, Switzerland
关键词
Probiotic; Lactobacillus paracasei; Atopic dermatitis; Topical corticoid; TEWL; IDQOL; SCORAD; Objective SCORAD; IgE; CCL17; PROBIOTIC STRAINS; STRATUM-CORNEUM; SCORAD INDEX; DRY SKIN; CHILDREN; LIFE; IGE;
D O I
10.1159/000499436
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background/Aims: Atopic dermatitis (AD) is a common disease in infancy, for which topical steroids are the first-line therapy but have side effects. Innovative approaches are needed to reduce the burden of AD and corticosteroid usage in infants. Methods: The once-daily consumption of heat-treated probiotic Lactobacillus paracasei GM-080 or placebo for 16 weeks as supplementary approach to topical treatment with fluticasone propionate cream was compared in AD infants aged 4-30 months. Outcomes were SCORAD and its subscores, TEWL, Infants' Dermatitis Quality of Life Index (IDQOL), corticoid "sparing effect," CCL17/TARC, and IgE status. Results: SCORAD, objective SCORAD, itching, and IDQOL decreased significantly (p < 0.001) over the treatment period in both treatment groups. Slight decreases (ns) were noted in TEWL in lesional and unaffected skin and CCL17 levels. There were no differences between the treatment groups. Total IgE increased over the treatment period in both groups, with significantly higher increase in the heat-treated probiotic group (p = 0.038). There was no evidence of a corticoid "sparing effect" by the probiotic. Conclusions: In this design, the probiotic L. paracasei was not beneficial as a complementary approach to topical corticosteroids in infants with AD. However, slight beneficial effects may have been masked by the moderate potency corticoid. (c) 2019 S. Karger AG, Basel
引用
收藏
页码:201 / 211
页数:11
相关论文
共 50 条
  • [21] Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trial
    Veien, NK
    Busch-Sorensen, M
    Stausbol-Gron, B
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (01) : 147 - 149
  • [22] Rice flour fermented with Lactobacillus paracasei CBA L74 in the treatment of atopic dermatitis in infants: A randomized, double- blind, placebo controlled trial
    D'Auria, Enza
    Panelli, Simona
    Lunardon, Luisa
    Pajoro, Massimo
    Paradiso, Laura
    Beretta, Silvia
    Loretelli, Cristian
    Tosi, Diego
    Perini, Matteo
    Bedogni, Giorgio
    Abdelsalam, Ahmed
    Fiorina, Paolo
    Bandi, Claudio
    Zuccotti, Gian Vincenzo
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [23] The effects of a topical lipid complex therapy on dogs with atopic dermatitis: a double blind, randomized, placebo-controlled study
    Hobi, Stefan
    Klinger, Christoph
    Classen, Janine
    Mueller, Ralf S.
    VETERINARY DERMATOLOGY, 2017, 28 (04) : 369 - +
  • [24] Lactobacillus rhamnosus GG in the middle ear after randomized, double-blind, placebo-controlled oral administration
    Tapiovaara, Laura
    Lehtoranta, Liisa
    Swanljung, Elisa
    Makivuokko, Harri
    Laakso, Sanna
    Roivainen, Merja
    Korpela, Riitta
    Pitkaranta, Anne
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2014, 78 (10) : 1637 - 1641
  • [25] Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial
    Berth-Jones, J
    Takwale, A
    Tan, E
    Barclay, G
    Agarwal, S
    Ahmed, I
    Hotchkiss, K
    Graham-Brown, RAC
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) : 324 - 330
  • [26] Azathioprine in severe adult atopic dermatitis: A double-blind, placebo-controlled, crossover trial
    Graham-Brown, RA
    Takwale, A
    Tan, E
    Barclay, G
    Agarwal, S
    Ahmed, I
    Hotchkiss, K
    Berth-Jones, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 343 - 343
  • [27] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ORAL CROMOLYN IN CHILDREN WITH ATOPIC-DERMATITIS AND DOCUMENTED FOOD HYPERSENSITIVITY
    BURKS, AW
    SAMPSON, HA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (02) : 417 - 423
  • [28] Oral Administration of Live and Dead Cells of Lactobacillus sakei proBio65 Alleviated Atopic Dermatitis in Children and Adolescents: a Randomized, Double-Blind, and Placebo-Controlled Study
    Irfan A. Rather
    Byung-Chun Kim
    Lee-Ching Lew
    Seong-Kwan Cha
    Jong Hwan Lee
    Gyeong-Jun Nam
    Rajib Majumder
    Jeongheui Lim
    Seul-Ki Lim
    Young-Joon Seo
    Yong-Ha Park
    Probiotics and Antimicrobial Proteins, 2021, 13 : 315 - 326
  • [29] TAPERING OF CORTICOSTEROID-THERAPY FOLLOWING EXACERBATION OF ASTHMA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    LEDERLE, FA
    PLUHAR, RE
    JOSEPH, AM
    NIEWOEHNER, DE
    ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (12) : 2201 - 2203
  • [30] Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial
    Donnino, Michael W.
    Andersen, Lars W.
    Berg, Katherine M.
    Chase, Maureen
    Sherwin, Robert
    Smithline, Howard
    Carney, Erin
    Ngo, Long
    Patel, Parth V.
    Liu, Xiaowen
    Cutlip, Donald
    Zimetbaum, Peter
    Cocchi, Michael N.
    CRITICAL CARE, 2016, 20